The largest database of trusted experimental protocols

Anti tigit antibody mbsa43

Manufactured by Thermo Fisher Scientific

The Anti-TIGIT antibody (MBSA43) is a laboratory reagent designed for research purposes. It is an antibody that specifically recognizes the TIGIT protein, which is a receptor involved in immune regulation. The core function of this antibody is to allow for the detection and study of TIGIT in various experimental settings.

Automatically generated - may contain errors

2 protocols using anti tigit antibody mbsa43

1

Autologous TILs Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Autologous CD8+ TILs were isolated from LUAD tissues and cultured for 72 h on plates coated with anti‐CD28 (37.51, eBioscience). Tumour organoids were harvested when their average diameters exceeded 50 μm. A portion of the organoid spheroids was digested into single cells for cell counting. The remaining organoid spheroids were cocultured with autologous CD8+ TILs at an E:T ratio of 20:1 in the presence of IL‐15 (R&D Systems), anti‐TIGIT antibody (MBSA43, eBioscience), their combination, or control IgG (BD Pharmingen). After 72 h of coculture, the organoids were dissociated into single cells using TrypLE Express and stained with 7‐AAD (eBioscience) for further flow cytometry analysis. To assess the time‐dependent killing of organoids, a green‐fluorescent probe specific for caspase 3/7 (Invitrogen), diluted at a ratio of 1:2000, was introduced into the coculture system to monitor apoptotic processes. The efficacy of T cell‐mediated cytotoxicity was evaluated over a 24‐h period using the LionheartFX, a live‐cell real‐time fluorescence imaging system developed by Biotek.
+ Open protocol
+ Expand
2

CFSE-based Cytotoxicity Assay for CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A standard 4‐h carboxyfluorescein diacetate succinimidyl ester (CFSE)‐based assay was used to assess the cytotoxicity of CD8+ T cells against H2228 cells. Briefly, H2228 cells were labelled with 10 μM CFSE (eBioscience) and then seeded onto plates as target cells. Subsequently, CD8+ T cells were isolated and exposed to H2228 cells at various E:T ratios. After incubation in the presence of blocking antibodies for 4 h, the cells were stained with 7‐AAD (eBioscience) followed by flow cytometry analysis. The blocking antibodies used were as follows: anti‐CD155 antibody (D171, GeneTex), anti‐TIGIT antibody (MBSA43, eBioscience), anti‐CD96 antibody (6A6, eBioscience) and control IgG (BD Pharmingen).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!